FDA Inspection 1099563 — PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd
The FDA completed an inspection of PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd on July 5, 2019 in Shaoxing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shaoxing (China)